Does your child with ADHD act out verbally and physically?

Consider enrolling your child in local research studies.

Those who qualify may receive*:

  • Payment that varies by study up to $700
  • No-cost, study-related care from a local doctor
  • No-cost study medication

No health insurance or referrals are needed.

Ready to get started? Click Here.

Your child with ADHD and angry behavior may qualify for local research studies.

ADHD (attention deficit hyperactivity disorder) is a common condition that affects many children. Symptoms of ADHD might include difficulty focusing or listening, trouble following directions or finishing tasks, or being easily distracted or hyperactive. Other children with ADHD might also have difficulty controlling their emotions. They may act out in verbal or physical ways.

This is called ADHD with impulsive aggression, or commonly referred to as “acting out”.  Life at home and at school can be disrupted by angry behavior such as screaming, shouting, hitting, kicking, and throwing things. Many children with ADHD may be medicated for their symptoms, but still have trouble controlling their emotions and behavior.

Better treatment options are needed for kids who struggle with ADHD and angry behavior. Right now, doctors are looking for kids who have ADHD and angry behavior to take part in local research studies.

But don’t delay — space is limited!

* In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study.  Reasonable payments will be made for participation and the length of the study may vary.

Ready to get started?

Click here.


Call 855-422-1354

How does it work?


Tell us a little bit about yourself


Answer some questions about your health


We will connect you to available studies in your area

Just takes a few minutes


AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.